{
    "type": "ETF",
    "ucits": true,
    "leverage": true,
    "derivatives": true,
    "swaps": false,
    "inverse": true,
    "replication_method": "physical",
    "complex_factors": "Leverage, Inverse exposure, Daily rebalancing compounding effect",
    "classification": "complex",
    "supporting_data": "The product is a Leverage Shares -3x Short Taiwan ETP Securities, which is a collateralised exchange traded security (ETP) with a leverage factor of -3x on the daily performance of the iShares MSCI Taiwan ETF. It is not capital protected and involves daily leverage rebalancing, which causes a compounding effect that can significantly deviate returns from -3 times the underlying over longer holding periods. The product is intended for sophisticated investors with a very short holding horizon (recommended 1 day) and requires understanding of leverage, inverse exposure, and compounding risks. The use of leverage beyond UCITS limits and the inverse leveraged strategy inherently make the product complex under MiFID II. The product is not a UCITS ETF but an ETP security, which is a different type. It uses physical replication of the underlying ETF but the leverage and inverse exposure introduce complexity. The product involves derivative-like risk exposures through its leveraged inverse strategy, although derivatives per se are not explicitly stated, the leverage and short exposure imply complex risk profiles. The risk indicator is high (6/7), reflecting high market and structural risk. The product documentation includes a comprehension alert stating it is not simple and may be difficult to understand. According to MiFID II rules and ESMA guidance, products with significant leverage, inverse exposure, and complex payoff profiles (such as daily leveraged inverse ETPs) are classified as complex. Therefore, this product is complex and requires an appropriateness assessment before sale to retail investors."
}